Christina Smolke, Antheia CEO

Say good­bye to plants: Syn­bio play­er An­theia earns new back­ers in quest to re­design flo­ra-de­rived med­i­cine man­u­fac­tur­ing

The age of syn­thet­ic bi­ol­o­gy is of­fi­cial­ly up­on us with su­per-uni­corns like Gink­go Bioworks chang­ing the game in terms of how in­vestors view those cell …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.